Publications by authors named "Elyse Stock"

Claim this Profile
R
Rimegepant orally disintegrating tablet for acute treatment of migraine: a plain language summary of a clinical study.
Robert Croop, Peter J Goadsby, David A Stock, Charles M Conway, Micaela Forshaw, Elyse G Stock

Pain Manag· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial.
Robert Croop, Richard B Lipton, David Kudrow, David A Stock, Lisa Kamen, Elyse G Stock

Lancet· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial.
Robert Croop, Peter J Goadsby, David A Stock, Charles M Conway, Micaela Forshaw, Elyse G Stock

Lancet· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine.
Richard B Lipton, Robert Croop, Elyse G Stock, David A Stock, Beth A Morris

N Engl J Med· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder.
Vladimir Coric, Howard H Feldman, Dan A Oren, Anantha Shekhar, Joseph Pultz, Elyse G Stock

Depress Anxiety· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole.
Dan L Zimbroff, Ronald N Marcus, George Manos, Elyse Stock, Robert D McQuade

J Clin Psychopharmacol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol.
Raisa Andrezina, Richard C Josiassen, Ronald N Marcus, Dan A Oren, George Manos, Elyse Stock

Psychopharmacology (Berl)· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study.
Gary Sachs, Raymond Sanchez, Ronald Marcus, Elyse Stock, Robert McQuade

J Psychopharmacol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective, multicenter, randomized, parallel-group, open-label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice: Broad Effectiveness Trial With Aripiprazole (BETA).
Rajiv Tandon, Ronald N Marcus, Elyse G Stock, Linda C Riera, Dusan Kostic

Schizophr Res· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial.
Eduard Vieta, Michel Bourin, Raymond Sanchez, Ronald Marcus, Elyse Stock

Br J Psychiatry· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.
Robert D McQuade, Elyse Stock, Ron Marcus, Darlene Jody, Neveen A Gharbia

J Clin Psychiatry· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study.
Teresa A Pigott, William H Carson, Anutosh R Saha, Anne F Torbeyns, Elyse G Stock

J Clin Psychiatry· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
Steven G Potkin, Anutosh R Saha, Mary J Kujawa, William H Carson, Mirza Ali, Elyse Stock

Arch Gen Psychiatry· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials.
Stephen R Marder, Robert D McQuade, Elyse Stock, Stephen Kaplita, Ronald Marcus

Schizophr Res· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis